Given a patient with a positive treponemal antibody confirmed by particle agglutination and a non‑reactive rapid plasma reagin (RPR), does this indicate previously treated syphilis or early primary syphilis, and what is the appropriate treatment and follow‑up?

Serologic Pattern Indicates Treated, Primary, or Late Latent Syphilis—Treat Now

This patient requires treatment with benzathine penicillin G 2.4 million units IM as a single dose, as the serologic pattern of positive treponemal tests with non-reactive RPR cannot reliably distinguish between previously treated syphilis, early primary syphilis, or late latent disease—and all scenarios except confirmed adequately-treated infection warrant therapy. 1

Understanding the Serologic Pattern

Your interpretation that this represents past infection is reasonable but clinically insufficient to withhold treatment. Here's why:

The laboratory correctly notes this pattern suggests three possibilities:

• Previously treated syphilis (serofast or serologic scar)
• Primary syphilis (before RPR becomes reactive)
• Late latent syphilis (RPR may become non-reactive over time)

Why RPR Can Be Non-Reactive in Active Syphilis

Primary syphilis has poor RPR sensitivity: Studies show RPR detects only 55-78% of primary syphilis cases compared to darkfield microscopy or PCR 2. In one large cohort, 26% of primary syphilis cases were RPR non-reactive 3. The nontreponemal test simply hasn't had time to become positive yet.

Late latent syphilis frequently shows non-reactive RPR: Approximately 39% of late latent cases are RPR non-reactive 3. The RPR naturally declines over years even without treatment, while treponemal antibodies persist for life 1.

Age matters: Patients over 35 years are 3.5 times more likely to have non-reactive RPR in primary syphilis and 4.3 times more likely in late latent disease 4. This is a critical pitfall—older patients are systematically under-detected by RPR screening.

Clinical Decision Algorithm

Step 1: Obtain Sexual History and Examination

• Look for: Painless genital ulcer/chancre (primary), rash on palms/soles, mucocutaneous lesions, lymphadenopathy (secondary)
• Ask about: Previous syphilis diagnosis and treatment dates, recent sexual exposures (within 90 days), symptoms

Step 2: Review Treatment History

• If documented adequate treatment (benzathine penicillin G 2.4 million units IM) with appropriate serologic follow-up showing ≥4-fold RPR decline → This is likely a serologic scar, no treatment needed
• If no documented treatment or inadequate documentation → Proceed to treatment

Step 3: Assess for Neurosyphilis Risk

Perform CSF examination if ANY of the following:

• Neurologic symptoms (meningitis, cranial nerve palsies, stroke-like symptoms)
• Ocular symptoms (uveitis, vision changes)
• Auditory symptoms (hearing loss, tinnitus)
• HIV infection with high RPR titers or neurologic symptoms 5

Do NOT perform routine CSF examination for asymptomatic patients with this serologic pattern 1.

Treatment Recommendation

Benzathine penicillin G 2.4 million units IM in a single dose 1

This regimen covers:

• Primary syphilis (if present)
• Secondary syphilis (if subclinical)
• Early latent syphilis (<1 year duration)

If Late Latent or Unknown Duration Is Suspected

Benzathine penicillin G 2.4 million units IM weekly × 3 doses (total 7.2 million units)

Use this extended regimen if:

• No documented exposure within past year
• No symptoms suggesting early infection
• Cannot confirm treatment history

Critical Pitfalls to Avoid

Pitfall #1: Assuming non-reactive RPR = no active infection This is the most dangerous assumption. The RPR is insensitive in both early primary and late latent disease 4, 3, 2.

Pitfall #2: Waiting for "better" serologic data The confirmatory TP-PA already confirms true treponemal antibody. No additional treponemal testing will clarify timing or activity 1.

Pitfall #3: Relying solely on patient recall of treatment Patients frequently misremember or were inadequately treated. Without documented proof of appropriate treatment AND serologic response, treat as new infection 1.

Pitfall #4: Missing the prozone phenomenon Though rare, very high antibody titers in secondary syphilis can cause false-negative RPR 6. The laboratory should have diluted the specimen, but if clinical suspicion is high for secondary syphilis, request dilutional testing.

Follow-Up Strategy

After treatment, obtain quantitative RPR at:

• 6 months (primary endpoint)
• 12 months (secondary endpoint)

Expected response: ≥4-fold decline in RPR titer (e.g., 1:16 → 1:4) indicates adequate treatment 1. However, since baseline RPR is non-reactive, you're monitoring for:

• RPR remaining non-reactive (good)
• RPR becoming reactive then declining (suggests early primary that was caught before seroconversion)
• RPR becoming reactive and staying elevated (treatment failure or reinfection)

Special Consideration: Trichomonas Co-infection

The patient also has detected T. vaginalis, which requires treatment with metronidazole 500 mg PO BID × 7 days OR tinidazole 2 g PO once. Treat sexual partners and advise abstinence until both infections are treated and partners are treated.

HIV Testing

All patients with syphilis must be tested for HIV 1. If not already done, order HIV testing today. HIV co-infection may require more intensive follow-up but does not change initial treatment for early syphilis 7.